8.1. Analysis.
Comparison 8 Variable doses of target of rapamycin inhibitors (TOR‐I) and calcineurin inhibitors (CNI): secondary outcomes, Outcome 1 New‐onset diabetes mellitus.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.